SecBot SecBot
DEFA14A ·Filed Jun 16, 2026

VXRT

Vaxart, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001213900-26-069053
Proxy solicitation materials
Actionable Insight • Neutral

The proxy contest is unlikely to succeed given the dissident's minimal ownership, but monitor for any large institutional shareholder support for the dissident slate or further escalation ahead of the July 16 meeting. The stock's OTC listing and volatile history mean any surprise outcome could drive outsized moves.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.5600
T+0 close · Jun 16, 2026 · via day close
Latest settled
−10.95%
T+60 · $0.4987
Vs SPY
−12.21%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 16 $0.5600entry
  2. T+1 · 5mo ago +1.79%α +3.03% · $0.5700
  3. T+5 · 5mo ago −6.00%α −4.09% · $0.5264
  4. T+20 · 4mo ago −5.36%α −6.21% · $0.5300
  5. T+60 · 2mo ago −10.95%α −12.21% · $0.4987

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vaxart management filed additional definitive proxy materials (DEFA14A) urging shareholders to vote FOR all six of its director nominees on the WHITE proxy card at the July 16, 2026 annual meeting, directly opposing a dissident group led by Daniel P. Houle that seeks to replace half the board. The letter from two newest independent directors defends the board's experience and recent strategic actions (BARDA stop-work response, Dynavax partnership, runway extension) while arguing the dissident nominees lack relevant qualifications. The outcome likely favors management given the dissident's small ~0.7% stake, but the contested election introduces modest uncertainty.

Key Financial Metrics

Vote
director election
Meeting
2026-07-16
Seats Contested
3

Key Facts

  • Annual meeting scheduled for July 16, 2026
  • Management recommends voting FOR all six director nominees on the WHITE proxy card
  • Dissident stockholder Daniel P. Houle nominated three candidates to replace half the board
  • Two newest independent directors (Breitmeyer and Finney) authored the letter endorsing the current board
  • Dissident group holds approximately 0.7% of outstanding shares (per prior PREC14A filing)
  • Board cites response to BARDA stop-work orders, Dynavax partnership, and runway extension as evidence of effective oversight

Financial Impact

No financial figures disclosed in this filing

Risk Factors

  • Dissident could gain unexpected support from dissatisfied shareholders if stock performance remains weak
  • Proxy contest could distract management from clinical and operational milestones (Phase 2b COVID-19 study, Dynavax partnership)
  • Low probability of dissident victory but binary outcome risk near meeting date

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001213900-26-069053
Document: 0001213900-26-069053-index-headers.html0001213900-26-069053
Document: 0001213900-26-069053-index.html0001213900-26-069053
Document: 0001213900-26-069053.txt0001213900-26-069053

Track record

23 reports on VXRT

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +37.66% at T+60 after the May 1, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $0.3700 Now $0.3600 +2.70% settles Feb 4
  2. Oct 19, 202628d ago 8-K Neutral 3/10 Entry $0.4900 Now $0.3600 −26.53% settles Jan 15
  3. Jul 28, 202615w ago 8-K Neutral 2/10 Entry $0.4800 to $0.4900 Now $0.3600 −25.00% ▲ +2.08% −2.53% vs SPY
  4. Jul 7, 202618w ago 8-K Neutral 4/10 Entry $0.5500 to $0.4500 Now $0.3600 −34.55% ▼ −18.18% −21.27% vs SPY
  5. Jul 6, 202619w ago DEFA14A Neutral 5/10 Entry $0.6200 to $0.4540 Now $0.3600 −41.94% ▼ −26.77% −28.93% vs SPY
  6. Jul 2, 202619w ago DEFA14A Bullish 5/10 Entry $0.6400 to $0.4500 Now $0.3600 −43.75% ▼ −29.69% −33.51% vs SPY
  7. Jul 2, 202619w ago 8-K Neutral 4/10 Entry $0.6400 to $0.4520 Now $0.3600 −43.75% ▼ −29.38% −32.80% vs SPY
  8. Jun 26, 202620w ago DEFA14A Neutral 4/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
  9. Jun 26, 202620w ago DEFA14A Neutral 3/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
  10. Jun 26, 202620w ago 8-K Mixed 5/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 16, 2026